Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lehmann

Showing results (391-400 of 446) with videos related to

Pageof 45
Sort By:
The Journal of Cell Biology|November 2, 2011
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4Johannes Backs, Barbara C Worst, Lorenz H Lehmann, et al.
American Heart Journal|August 1, 1994
Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillationT J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology|October 15, 1993
Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarctionT J Lessmeier, M H Lehmann, R T Steinman, et al.
Journal of the American College of Cardiology|May 1, 1993
Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapyM D Meissner, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology|June 30, 2007
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT)John D Fisher, Alfred E Buxton, Kerry L Lee, et al.
Circulation|November 15, 1995
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndromeA J Moss, W Zareba, J Benhorin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responsesJuan J Rojas, Lien Van Hoecke, Miquel Conesa, et al.
The New England Journal of Medicine|March 3, 2006
Circumferential pulmonary-vein ablation for chronic atrial fibrillationHakan Oral, Carlo Pappone, Aman Chugh, et al.
International Journal of Antimicrobial Agents|April 30, 2013
Acute administration of antibiotics modulates intestinal capillary perfusion and leukocyte adherence during experimental sepsisN A Al-Banna, D Pavlovic, V H Bac, et al.
Circulation|September 7, 2000
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2I Splawski, J Shen, K W Timothy, et al.
Pageof 45

Showing results (391-400 of 446) with videos related to

Sort By:
Pageof 45
The Journal of Cell Biology|November 2, 2011
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4Johannes Backs, Barbara C Worst, Lorenz H Lehmann, et al.
American Heart Journal|August 1, 1994
Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillationT J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology|October 15, 1993
Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarctionT J Lessmeier, M H Lehmann, R T Steinman, et al.
Journal of the American College of Cardiology|May 1, 1993
Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapyM D Meissner, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology|June 30, 2007
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT)John D Fisher, Alfred E Buxton, Kerry L Lee, et al.
Circulation|November 15, 1995
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndromeA J Moss, W Zareba, J Benhorin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responsesJuan J Rojas, Lien Van Hoecke, Miquel Conesa, et al.
The New England Journal of Medicine|March 3, 2006
Circumferential pulmonary-vein ablation for chronic atrial fibrillationHakan Oral, Carlo Pappone, Aman Chugh, et al.
International Journal of Antimicrobial Agents|April 30, 2013
Acute administration of antibiotics modulates intestinal capillary perfusion and leukocyte adherence during experimental sepsisN A Al-Banna, D Pavlovic, V H Bac, et al.
Circulation|September 7, 2000
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2I Splawski, J Shen, K W Timothy, et al.
Pageof 45